|
Volumn 42, Issue 3, 2014, Pages 235-237
|
18F-FDG PET and PET/CT in diagnosis and treatment monitoring of pyrexia of unknown origin due to tuberculosis with prominent hepatosplenic involvement
|
Author keywords
18F FDG PET CT; Infectious disease; Pyrexia of unknown origin; Second line antitubercular therapy; Tuberculosis
|
Indexed keywords
CYCLOSERINE;
ETHAMBUTOL;
ETHIONAMIDE;
FLUORODEOXYGLUCOSE F 18;
ISONIAZID;
KANAMYCIN;
LEVOFLOXACIN;
PYRAZINAMIDE;
RIFAMPICIN;
RADIOPHARMACEUTICAL AGENT;
TUBERCULOSTATIC AGENT;
ADULT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
BILIRUBIN BLOOD LEVEL;
BLOOD CELL COUNT;
BONE MARROW EXAMINATION;
CALCIUM BLOOD LEVEL;
CALCIUM URINE LEVEL;
CASE REPORT;
CLINICAL EXAMINATION;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
DIFFERENTIAL DIAGNOSIS;
DRUG WITHDRAWAL;
ECHOGRAPHY;
EPITHELIOID CELL;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
FOLLOW UP;
GIANT CELL;
GRANULOMATOUS HEPATITIS;
HISTOPATHOLOGY;
HOSPITALIZATION;
HUMAN;
KIDNEY FUNCTION TEST;
LIVER BIOPSY;
LIVER PARENCHYMA;
LOSS OF APPETITE;
LUNG NODULE;
LUNG SARCOIDOSIS;
LYMPHADENOPATHY;
METABOLISM;
MYCOBACTERIUM TUBERCULOSIS;
MYCOBACTERIUM TUBERCULOSIS TEST KIT;
PATIENT MONITORING;
POLYMERASE CHAIN REACTION;
PYREXIA IDIOPATHICA;
TUBERCULOSIS;
WEIGHT REDUCTION;
WORK;
COMPLICATION;
COMPUTER ASSISTED TOMOGRAPHY;
DIAGNOSTIC USE;
FEVER;
LIVER;
MULTIMODAL IMAGING;
POSITRON EMISSION TOMOGRAPHY;
PROCEDURES;
RADIOGRAPHY;
SCINTISCANNING;
SPLEEN;
TREATMENT OUTCOME;
TUBERCULOSIS, HEPATIC;
TUBERCULOSIS, SPLENIC;
WHOLE BODY IMAGING;
ADULT;
ANTITUBERCULAR AGENTS;
DIAGNOSIS, DIFFERENTIAL;
FEMALE;
FEVER;
FLUORODEOXYGLUCOSE F18;
FOLLOW-UP STUDIES;
HUMANS;
LIVER;
MULTIMODAL IMAGING;
POSITRON-EMISSION TOMOGRAPHY;
RADIOPHARMACEUTICALS;
SPLEEN;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
TUBERCULOSIS;
TUBERCULOSIS, HEPATIC;
TUBERCULOSIS, SPLENIC;
WHOLE BODY IMAGING;
|
EID: 84906963979
PISSN: 00914916
EISSN: None
Source Type: Journal
DOI: 10.2967/jnmt.113.132985 Document Type: Article |
Times cited : (8)
|
References (4)
|